Abstract.
Hypertensive emergencies secondary to renal diseases were treated with nicardipine in three children. Nicardipine is the first intravenously administered dihydropyridine calcium channel blocker. Its physiological actions include vasodilation, with limited effects on the chronotropic and inotropic function of the myocardium. Nicardipine, starting at 5 μg/kg per min and then continued at a maintenance infusion of 1 – 3 μg/kg per min, effectively controlled the mean arterial pressure in the three patients. Apart from occasional superficial thrombophlebitis in a fourth patient, no adverse effects were noted.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received February 26, 1997; received in revised form July 14, 1997; accepted July 16, 1997
Rights and permissions
About this article
Cite this article
Michael, J., Groshong, T. & Tobias, J. Nicardipine for hypertensive emergencies in children with renal disease. Pediatr Nephrol 12, 40–42 (1998). https://doi.org/10.1007/s004670050400
Published:
Issue Date:
DOI: https://doi.org/10.1007/s004670050400